GlassScriptPhysician profile
Sandra Marie Chaplin
NPI 1437498037
$2,591.45
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $326 · 2022: $2,013 · 2023: $139 · 2024: $113.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Senseonics, Incorporated | $1,600.00 | 2022 | |
| Glaxosmithkline, LLC. | $150.78 | 2022 | |
| Janssen Pharmaceuticals, INC | $111.61 | 2021-2023 | Xarelto |
| Cardiovascular Systems INC. | $67.36 | 2021-2022 | |
| Biotronik INC. | $62.60 | 2021-2024 | Passeo-18, Pulsar-18 T3 |
| Smith+Nephew, INC. | $61.22 | 2021-2022 | |
| Angiodynamics, INC. | $45.34 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Endologix LLC | $44.98 | 2021-2023 | Ovation Ix Iliac Stent Graft, Afx2 Bifurcated Endograft System |
| Davol INC. | $44.59 | 2023-2024 | Phasix Mesh |
| Redhill Biopharma INC. | $36.47 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $31.46 | 2021 | |
| Innocoll Pharmaceuticals Limited | $31.18 | 2021-2022 | |
| Integra Lifesciences Corporation | $28.71 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $26.73 | 2022-2023 | Andexxa |
| Lemaitre Vascular, INC. | $22.46 | 2023 | Restoreflow |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $19.97 | 2023 | |
| Terumo Medical Corporation | $18.57 | 2021 | |
| Abbott Laboratories | $18.18 | 2023 | Diamondback Peripheral |
| Boston Scientific Corporation | $17.62 | 2021 | |
| Cordis US Corp. | $17.46 | 2024 | S.M.A.R.T. Control |
| Medela LLC | $17.10 | 2021 | |
| Eagle Pharmaceuticals, INC. | $16.63 | 2023 | |
| W. L. Gore & Associates, INC. | $16.47 | 2021 | |
| Bard Peripheral Vascular, INC. | $16.06 | 2024 | Crosser Iq |
| Abbvie INC. | $15.60 | 2021 | |
| Pfizer INC. | $15.51 | 2021 | |
| Veryan Medical Incorporated | $12.82 | 2021 | |
| Teleflex LLC | $12.52 | 2022 | |
| Ambu INC. | $11.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Chaplin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.